Skip to main content
SpringerLink
Log in

Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction

  • Original Article
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to determine the involvement of non-alcoholic fatty liver disease (NAFLD) in myocardial infarction patients and its relation with carotid intima-media thickness (CIMT).

Methods

This study consisted of 224 patients divided into three groups: those with myocardial infarction (MI), stable coronary artery disease (CAD), and normal coronary artery. Measurement of CIMT and abdominal ultrasonography for hepatosteatosis was performed in all participants.

Results

NAFLD was significantly more frequent among MI patients compared to the other groups. There was a significant difference between CAD and the presence of NAFLD (p < 0.05). Also, we found significant correlations between the severity of CAD and hepatosteatosis grade (r = 0.648, p < 0.001), CAD and CIMT (r = 0.594, p < 0.001), and NAFLD and CIMT (r = 0.233, p = 0.005). NAFLD was also significantly correlated with the severity of CAD (r = 0.607, p < 0.001), and the grade of NAFLD significantly correlated with CIMT (r = 0.606, p < 0.001).

Conclusion

Patients with more severe CAD were more likely to have NAFLD. In addition, hepatosteatosis may be associated with coronary plaque instability and high fatty volume. Patients with NAFLD should be screened regularly for other cardiovascular risk factors, and the presence of fatty liver may help better classify these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.

    Article  PubMed  CAS  Google Scholar 

  2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:99–112.

    Article  Google Scholar 

  3. Musso G, Gambino R, Bo S, et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabet Care. 2008;31:562–8.

    Article  CAS  Google Scholar 

  4. Marchesini G, Marzocchi R, Agostini F, et al. Non-alcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16:421–7.

    Article  PubMed  CAS  Google Scholar 

  5. Assy N, Kaita K, Mymin D, et al. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci. 2000;45:1929–34.

    Article  PubMed  CAS  Google Scholar 

  6. Donati G, Stagni B, Piscaglia F, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53:1020–3.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Akahoshi M, Amasaki Y, Soda M, et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki. Jpn Hypertens Res. 2001;24:337–43.

    Article  CAS  Google Scholar 

  8. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–50.

    Article  PubMed  Google Scholar 

  9. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med. 2007;24:1–6.

    Article  PubMed  CAS  Google Scholar 

  10. Brea A, Mosquera D, Martin E, et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis. A case control study. Arterioscler Thromb Vasc Biol. 2005;25:1045–50.

    Article  PubMed  CAS  Google Scholar 

  11. Thygesen K, Alpert SA, White HD, et al. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–38.

    Article  PubMed  Google Scholar 

  12. Third report of the national cholesterol education program. (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATP III) final report. Circulation. 2002;106:3143–421.

    Google Scholar 

  13. Lang RM, Bierig M, Devereux RB, et al. American society of echocardiography nomenclature and standards committee; task force on chamber quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.

    Article  PubMed  Google Scholar 

  14. Leaman DM, Brower RW, Meester GT, et al. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981;63:285–9.

    Article  PubMed  CAS  Google Scholar 

  15. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.

    Article  PubMed  CAS  Google Scholar 

  16. Osawa H, Morry Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clic Ultrasound. 1996;24:25–9.

    Article  CAS  Google Scholar 

  17. el-Hassan AY, Ibrahim EM, al-Mulhim FA, et al. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol. 1992;65:774–8.

    Article  PubMed  CAS  Google Scholar 

  18. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol. 2002;17:1136–43.

    Article  PubMed  CAS  Google Scholar 

  19. Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischaemic heart disease. World J Gastroenterol. 2005;11:4838–42.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Targher G, Bertolini L, Padovani R, et al. Increased prevalence of cardiovascular disease among type 2 diabetic patients with nonalcoholic fatty liver disease. Diabet Med. 2006;23:403–9.

    Article  PubMed  CAS  Google Scholar 

  21. Arslan U, Türkoğlu S, Balcioğlu S, et al. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18:433–6.

    Article  PubMed  Google Scholar 

  22. Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73.

    Article  PubMed  CAS  Google Scholar 

  23. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profi le in nonalcoholic fatty liver disease. Hepatology. 2005;42:473–80.

    Article  PubMed  Google Scholar 

  24. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–8.

    Article  PubMed  CAS  Google Scholar 

  25. Targher G, Zenari L, Bentolini L, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabet Care. 2006;29:1325–30.

    Article  Google Scholar 

  26. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262–9.

    Article  PubMed  CAS  Google Scholar 

  27. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–67.

    Article  PubMed  Google Scholar 

  28. Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54:3541–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology Department, Van High Education and Research Hospital, Van, Turkey

    Hasan Öztürk, Aytaç Akyol, Şenay Öztürk, Serkan Akdağ, Hakkı Şimşek & Musa Şahin

  2. Cardiology Department, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey

    Hasan Ali Gümrükçüoğlu

  3. Cardiology Department, Samsun Education and Research Hospital, Samsun, Turkey

    Mehmet Yaman

  4. Cardiology Department, Faculty of Medicine, Ordu University, Ordu, Turkey

    Zeki Yüksel Günaydın

  5. Radiology Department, Faculty of Medicine, Ordu University, Ordu, Turkey

    Hasan Öztürk

Authors
  1. Hasan Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hasan Ali Gümrükçüoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aytaç Akyol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Şenay Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Serkan Akdağ
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hakkı Şimşek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Musa Şahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zeki Yüksel Günaydın
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hasan Öztürk.

Ethics declarations

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.

Human rights statements and informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Öztürk, H., Gümrükçüoğlu, H.A., Yaman, M. et al. Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction. J Med Ultrasonics 43, 77–82 (2016). https://doi.org/10.1007/s10396-015-0649-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-015-0649-x

Keywords

Search

Navigation